Skip to main content
GutCited

Lactobacillus reuteri Gastroesophageal Reflux Disease (GERD)

C

Limited evidence that L. reuteri improves regurgitation in infants. Adult GERD evidence is weak.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dlactobacillus\u002Dreuteri\u0026condition\u003Dgerd'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

結論

Limited evidence that L. reuteri improves regurgitation in infants. Adult GERD evidence is weak.

Key Study Findings

basic science
Lactobacillus reuteri E9 Regulates Sleep Disorders Through Its Metabolite GABA.
Dose: Lactobacillus reuteri E9 (dose not specified) vs: Placebo 効果: None < 0.05
Review
The evidence for probiotics in the treatment of digestive disorders in the pediatric population.
Dose: None vs: None Outcome: None 効果: None None

対象集団: Pediatric population

Key Statistics

2

研究数

250

参加者数

Positive

C

グレード

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
100 million - 5 billion CFU/day
infantilecolic:
100 million CFU/day (DSM 17938 strain, 5 drops)
adultgisupport:
1-5 billion CFU/day

上限量: Well-tolerated up to 10 billion CFU/day in clinical trials

研究で検討された用量

用量 期間 効果 N
Lactobacillus reuteri E9 (dose not specified) -- Positive --
None -- Mixed --

推奨摂取タイミング: Before meals or on empty stomach; for infants, add drops to breast milk or formula

Safety & Side Effects

報告されている副作用

  • Mild gas in initial days of use
  • Occasional increased fussiness in infants during adjustment (transient)
  • Rare loose stools
  • Very rare: bacteremia in immunocompromised individuals

既知の相互作用

  • Antibiotics (may reduce probiotic viability; space dosing 2 hours apart)
  • Immunosuppressants (theoretical risk in immunocompromised patients)
  • Proton pump inhibitors (altered gastric pH may affect colonization)

耐容上限摂取量: Well-tolerated up to 10 billion CFU/day in clinical trials

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Lactobacillus reuteri help with Gastroesophageal Reflux Disease (GERD)?
Based on 2 studies with 250 participants, there is limited but promising evidence that Lactobacillus reuteri may support Gastroesophageal Reflux Disease (GERD) management. Our evidence grade is C (Some Evidence).
How much Lactobacillus reuteri should I take for Gastroesophageal Reflux Disease (GERD)?
Studies have used various dosages. A commonly studied range is 100 million - 5 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Lactobacillus reuteri?
Reported side effects may include Mild gas in initial days of use, Occasional increased fussiness in infants during adjustment (transient), Rare loose stools, Very rare: bacteremia in immunocompromised individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Lactobacillus reuteri and Gastroesophageal Reflux Disease (GERD)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 2 peer-reviewed studies with 250 total participants. The overall direction of effect is positive.

Related Evidence

に関する他の成分: Gastroesophageal Reflux Disease (GERD)

Lactobacillus reuteri 他の症状・状態について

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。